Prestige Wealth Inc. (NASDAQ: PWM) Plans to be Renamed to Aurelion Inc. (NASDAQ: AURE) Subject to Approvals
$100 Million Private Placement & $50 Million Senior Debt Facility
Antalpha Anchors [...] Read more »
Antalpha Anchors $150 Million Financing in Aurelion Treasury; Initiating NASDAQ’s First Tether Gold Treasury
Prestige Wealth Inc. (NASDAQ: PWM) Plans to be Renamed to Aurelion Inc. (NASDAQ: AURE) Subject to Approvals
$100 Million Private Placement & $50 Million Senior Debt Facility
Antalpha Anchors [...] Read more »
Nilo Therapeutics startet mit einer Serie-A-Finanzierung in Höhe von 101 Mio. USD zur Entwicklung einer neuen Medikamentenklasse, die auf neuronale Schaltkreise bei Immunerkrankungen abzielt, und ernennt Kim Seth zum Chief Executive Officer
NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) — Nilo Therapeutics, ein Biotechnologieunternehmen, das neuronale Schaltkreise nutzt, um die Immunhomöostase bei Krankheiten wiederherzustellen, startete heute mit einer [...] Read more »
Lancement de Nilo Therapeutics avec un financement de série A de 101 millions de dollars en vue de développer une nouvelle classe de médicaments ciblant les circuits neuronaux dans les maladies immunitaires, et nomination de Kim Seth au poste de directeur général
NEW YORK, 09 oct. 2025 (GLOBE NEWSWIRE) — Nilo Therapeutics, une société de biotechnologie qui mise sur les circuits neuronaux pour rétablir l’homéostasie immunitaire chez les patients malades, [...] Read more »
Nilo Therapeutics é lançada com financiamento de US $101 milhões da Série A para promover uma nova classe de medicamentos direcionados a circuitos neurais em doenças imunológicas e nomeia Kim Seth como CEO
NOVA YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) — A Nilo Therapeutics, uma empresa de biotecnologia que utiliza circuitos neurais para restaurar a homeostase imunológica em doenças, foi lançada hoje com um [...] Read more »
Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer
NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) — Nilo Therapeutics, a biotechnology company harnessing neural circuits to restore immune homeostasis in disease, launched today with a $101 million Series A financing led by The Column Group [...] Read more »
AgDevCo expands its portfolio in Zambia with a new investment in the poultry sector
LONDON, Oct. 02, 2025 (GLOBE NEWSWIRE) — Specialist agriculture investor AgDevCo is pleased to announce its latest investment in Hybrid, an integrated poultry producer located in Zambia.
Hybrid [...] Read more »
Kensana Health Lands $120 million from GEM, Fuelling a Global Plant Based Medicine Revolution
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) — Kensana Health Inc. (“Kensana”) today announced it has entered into a share subscription facility of up to $120 million with GEM Global Yield LLC SCS ("GEM"), a [...] Read more »
AirX réalise une levée de fonds de 115 millions d’euros sur le marché obligataire nordique, soutenue par des investisseurs institutionnels internationaux
LONDRES, 18 sept. 2025 (GLOBE NEWSWIRE) — Read more »
AirX تغلق حملة إصدار سندات بقيمة 115 مليون يورو بدعم من كبار المستثمرين المؤسسيين الدوليين
لندن , Sept. 18, 2025 (GLOBE NEWSWIRE) —
أعلنت Read more »